NCT04746885 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Aderem A, Ulevitch RJ
Toll-like receptors in the induction of the innate immune response. Nature. 2000 Aug 17;406(6797):782-7. Review.
Axelsson A, Lindgren F
[Firecrackers--a risk of hearing injuries?]. Lakartidningen. 1987 Apr 15;84(16):1341-6. Swedish.
Meguro A, Kuribayashi R, Sakurada T, Sekine T, Aida H, Abe T
[Intravascular hemolysis due to residual shunt after patch closure of VSD: a case report]. Kyobu Geka. 1992 Jun;45(6):537-40. Japanese.
Miles EA, Calder PC
Modulation of immune function by dietary fatty acids. Proc Nutr Soc. 1998 May;57(2):277-92. Review.

Effect of DHA on Proinflammatory Cytokines Including Platelets Activating Factor (PAF) and it's Role in Prevention of Necrotizing Enterocolitis in Preterm/Very Low Birth Weight Neonates

Details for clinical trial NCT04746885

Clinical trial NCT04746885 - References